At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,695 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Association of Early Myocardial Injury With Major Adverse Outcomes in Patients With COVID-19
In Brief
An observational study for COVID-19 and 2 related conditions. Completed, enrolled 4,695 participants across 1 site.
Detailed Summary
The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the study team will explore the association between high-sensitivity troponin I (TnI) levels and clinical characteristics, biomarkers, cardiac tests data and treatment approaches to uncover the potential mechanisms responsible for COVID-19 induced myocardial injury.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMay 2020
First PostedMay 2020
Primary CompletionMar 2022
TodayJul 2026
First PostedMay 21, 2020
Enrollment StartMay 8, 2020
Primary CompletionMar 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.1 years ago